A PHASE 1B/2A, RANDOMIZED, MULTI-CENTER, OPEN-LABEL, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF ORAL SYN-004 ON THE PHARMACOKINETICS OF INTRAVENOUS CEFTRIAXONE IN HEALTHY ADULT SUBJECTS WITH A FUNCTIONING ILCOSTOMY

Registry ID

SB-1-004-003

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

SYNTHETIC BIOLOGICS, INC

Start date

2015-06-08

Last update

2015-02-20

Conditions

• CLOSTRIDIUM DIFFICILE INFECTION

Related clinical trials

• AN ADAPTIVE BASKET TRIAL TO EVALUATE EFFICACY OF LYOPHILIZED FECAL MICROBIOTA TRANSPLANTATION IN MANAGEMENT OF IRRITABLE BOWEL SYNDROME-DIARRHEA PREDOMINANT OR PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
• AN EXPLORATORY, OPEN-LABEL, OLIGO-CENTER STUDY TO EVALUATE THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF INTRAVENOUS DNV3837 IN SUBJECTS WITH CLOSTRIDIUM DIFFICILE INFECTION
• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CRS3123 COMPARED WITH ORAL VANCOMYCIN IN ADULTS WITH CLOSTRIDIOIDES DIFFICILE INFECTION
• A PHASE 3 OPEN-LABEL CLINICAL STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF REBIOTIX RBX2660 (MICROBIOTA SUSPENSION) IN SUBJECTS WITH RECURRENT CLOSTRIDIUM DIFFICILE INFECTION
• A MULTI-CENTER, DOUBLE BLIND, RANDOMIZED STUDY COMPARING THE EFFICACY OF LYOPHILIZED STERILE FECAL FILTRATE TO LYOPHILIZED FECAL MICROBIOTA TRANSPLANTATION (FMT) IN THE MANAGEMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (CDI)
• A PHASE I, OPEN-LABEL, SINGLE-CENTRE STUDY OF THE SAFETY AND EFFICACY OF MET-2 IN PATIENTS WITH RECURRENT CLOSTRIDIUM DIFFICILE INFECTION (CDI)

View on source registry